14 completed. 14 Phase 2, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 14 |
| Phase 3 | 6 | Completed 6 |
Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 35 | 2022-07-09 | 2026-04-06 |
| Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 1208 | 2021-12-30 | 2025-03-20 |
| New Therapies and Biomarkers for Chagas Infection Benznidazole, Nifurtimox - Trypanosoma Cruzi Infection, Chagas Disease | Phase 2 | Completed | University of Texas, El Paso | 450 | 2019-12-18 | 2024-07-17 |
| Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense Fexinidazole - Trypanosomiasis, African, Sleeping Sickness | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 45 | 2019-09-29 | 2025-01-30 |
| Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease Fexinidazole, Placebo Oral Tablet - Chagas' Disease (Chronic) Nos | Phase 2 | Completed | Drugs for Neglected Diseases | 45 | 2017-11-13 | 2020-09-23 |
| Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. Benznidazole - Chagas Disease, Trypanosoma Cruzi Infection | Phase 2 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 238 | 2017-04-21 | 2023-12-19 |
| Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 208 | 2016-10-11 | 2025-09-17 |
| Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy Treatment with G-CSF (Granulocyte colony stimulating factor), Placebo saline - Chronic Chagasic Myocarditis | Phase 2 | Completed | Hospital Sao Rafael | 70 | 2015-09-01 | 2020-08-24 |
| Cardiac Rehabilitation in Chagas Heart Failure Exercise, nutritional and pharmaceutical counseling - Chagas Disease, Chagas Cardiomyopathy | Phase 2 / Phase 3 | Completed | Evandro Chagas National Institute of Infectious Disease | 12 | 2013-05-01 | 2015-08-05 |
| Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 394 | 2012-10-01 | 2018-02-20 |
| A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267) Posaconazole, Placebo for posaconazole, Benznidazole - Chagas Disease | Phase 2 | Completed | Merck Sharp & Dohme LLC | 120 | 2011-07-06 | 2018-08-27 |
| Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole Benznidazole, Posaconazole - Chagas Disease | Phase 2 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 78 | 2010-09-01 | 2013-09-10 |
| Trial of DB289 for the Treatment of Stage I African Trypanosomiasis DB289, Pentamidine - African Trypanosomiasis | Phase 2 | Completed | Immtech Pharmaceuticals, Inc | 111 | 2003-02-01 | 2008-12-08 |
| A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis DB289 - Trypanosomiasis, African | Phase 2 | Completed | Immtech Pharmaceuticals, Inc | 30 | 2001-08-01 | 2008-12-05 |
Chagas Disease (7) · Trypanosomiasis, African (7) · Infections (3) · Bronchiolitis Obliterans Syndrome (1) · Chagas Cardiomyopathy (1) · Neglected Diseases (1) · Parasitic Diseases (1) · Pyloric Stenosis, Hypertrophic (1)
Euglenozoa Infections (14) · Protozoan Infections (14) · Vector Borne Diseases (14) · Parasitic Diseases (13) · Infections (11) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Cardiomyopathies (1) · Cardiovascular Diseases (1) · Digestive System Diseases (1) · Disease Attributes (1) · Gastric Outlet Obstruction (1)
benzonidazole (4) · fexinidazole (3) · Nifurtimox (2) · posaconazole (2) · Eflornithine (1) · Exercise (1) · Granulocyte Colony-Stimulating Factor (1) · Pentamidine (1) · SCYX 7158 (1) · Sodium Chloride (1) · Therapeutics (1)
Drugs for Neglected Diseases (6) · Hospital Universitari Vall d'Hebron Research Institute (2) · Immtech Pharmaceuticals, Inc (2) · Evandro Chagas National Institute of Infectious Disease (1) · Hospital Sao Rafael (1) · Merck Sharp & Dohme LLC (1) · University of Texas, El Paso (1)
Democratic Republic of the Congo (4) · Brazil (3) · Guinea (3) · Republic of the Congo (3) · Spain (3) · Angola (1) · Argentina (1) · Bolivia (1) · Central African Republic (1) · Colombia (1) · Malawi (1) · Uganda (1)
Andrea S Sousa, PhD (1) · Bruno SF Souza, MD, Msc (1) · Carolina T Macedo, MD, Msc (1) · Christian Burri, MSc, PhD (1) · Clarissa LM Souza, MD (1) · Enock Matovu, Prof (1) · Faustino Torrico, M.D., Ph.D (1) · Gomez Jordi, MD (1) · Igor C Almeida, D.Sc. (1) · Israel Molina, PhD (1) · Joaquim Gascon, M.D., Ph.D (1) · Milena BP Soares, PhD (1)
PMID 26881924, PMID 24827034, PMID 28231946, PMID 29113731, PMID 32293523, PMID 34972765, PMID 35757326, PMID 36460027, PMID 38218194, PMID 38218195, PMID 40288400, PMID 42772313
2016 (2), U01AI129783 (1)